Abstract-Critically ill patients are commonly linked to stress-induced hyperglycaemia which relates to insulin resistance and the risk of per-diagnosed with diabetes and other metabolic illnesses. Thus, it is essential to choose the best practice of blood glucose management in order to reduce morbidity and mortality rates in intensive care unit. This study is focusing on clinical data of 210 critically ill patients in Hospital Tengku Ampuan Afzan (HTAA), Kuantan who underwent Intensive Insulin Therapy which utilized a sliding scale method. Patients were identified in two main groups of diabetic (123) and non-diabetic (87) where stochastic model is generated to observe 90% confidence interval of insulin sensitivity. Blood glucose levels comparison between these two cohorts is conducted to observe the percentage of blood glucose levels within targeted band of 4.4 -10.0 mmol/L. It is found that 82% of BG levels are within targated band for nondiabetes cohort under stochastic targeted (STAR) glycaemic control protocol. However, only 59.6% and 70.6% BG levels are within targeted band for diabetes cohort for insulin infusion therapy used in HTAA and STAR protocols. Thus, further investigation on blood glucose control protocol for diabetes patients is required to increase the reliability and efficacy of current practice despite of patient safety.
I. INTRODUCTION
People diagnosed with chronic diseases such as heart disease and diabetes has significantly increased in recent years [1] . These diseases are life-threatening and may cause mortality if it is untreated especially in intensive care unit (ICU) [2, 3] . Usually patients admitted in ICU will experience stressinduced hyperglycaemia (high blood glucose level) [4] . The stress response of a critically ill patient experiences is highly complex, variable and dynamic [5] , making safe, effective control of blood glucose (BG) difficult. Thus, a number of studies may have failed to achieve consistent, safe and effective GC [6] [7] [8] [9] .
In fact an accurate computerized model-based glycaemic control (GC) protocol has been applied in ICU [10] [11] [12] [13] since 2011.This model-based method can identify evolving patientspecific parameters and customize clinical treatment based on patient's metabolic state known as stochastic targeted (STAR) GC protocol. STAR which is tablet-computer-based uses a clinically validated physiological model of the insulin-glucose system [14] and a population-based model of insulin sensitivity (SI) variability [15] . This protocol will generate optimal patient-specific insulin and nutrition treatments that maximize control and nutrition, while maintaining a maximum 5% risk of hypoglycaemia (low blood sugar level) incidences [16] . Practically STAR has been the standard of care in Christchurch Hospital ICU, Christchurch, New Zealand, and in the Kalman Pandy Hospital ICU, Gyula, Hungary, since 2011. STAR is the based on modification and improvement of Specialized Relative Insulin and Nutrition Tables (SPRINT) [9] .
Besides, the insulin infusion therapy (IIT) protocol is reportedly reduced BG levels besides morbidity and mortality in ICU. In some cases, IIT has a drawback in regulating normal BG level if high insulin dose is given to the patient which can lead to hypoglycaemia (low blood sugar level) [17] . The current IIT practice [3] is solely dependent on insulin infusion without participating the nutrition input in the same protocol despite the aim of protocol is to attain BG level between 4.4 to 10.0 mmol/L. Hence the performance of current GC practice in Malaysia ICU especially patient with diabetes is utterly vague although previous studies suggested that IIT may reduce risk of mortality and morbidity.
Although issues on the efficacy and safety of GC protocols that have been used in ICU is becoming concern [6, 8, 12, 18] , the needs to regulate normal BG level in intensive care unit is highly prioritized in order to reduce the risk of mortality and to ensure patient's co-morbidities from becoming worst. Thus, to aid the clinical workload GC protocol can be computerized by applying model-based control system that tolerates with the combination of insulin-nutrition inputs simultaneously given to the patients. The output of this control system is to obtain normal BG level within 4.4 -10.0 mmol/L. Hence, this study is mainly focused on the performance of computerized STAR GC protocol in Malaysia ICU cohort. Also, comparison of BG levels and SI between diabetes and non-diabetes critically-ill patients will be computed to discover either STAR protocol is reliable in controlling BG levels under diabetes circumstances.
II. METHODOLOGY

A. Clinical data
Blood glucose levels, nutrition and insulin infusion inputs of 210 critically-ill patients treated under Insulin Infusion Protocol [19] and Enteral and Parenteral Nutrition Protocol [20] 
B. ICU Management Protocols
The management protocols that have been practising in Intensive Care Unit of Hospital Tengku Ampuan Afzan for clinical data are Insulin Infusion and Enteral and Parenteral Nutrition.
1) Insulin Infusion Protocol (IIT)
This protocol commenced once BG level greater than 10.0 mmol/L for the continue reading within 1 h. Besides soluble insulin of 50 unit in 50 ml 0.9% NaCl is used as continuous intravenous insulin infusion. The targeted blood glucose level band is set to be within 4.4 -10 mmol/L specifically for Malaysian cohort. Thus to maintain patient BGLs within this targated band, BGL is initially monitored hourly then the next measurement can be up to 2 hours apart if no requirement of insulin rate of change within this timeframe. The frequency of monitoring BGL can be reduced up to 4 hours apart once BGL is continuously within the targeted band.
If BGL is > 10.0 mmol/L, patient will be re-checked again within an hour. Then, if BGL still > 10.0 mmol/L, IIT will be commenced. The initial insulin infusion rate is presented in Table II . While insulin is infused to the patient, initiate or maintain 10% dextrose infusion at 25 ml/h until Enteral Nutrition (EN) tolerated (i.e. 40 ml/h with 200 ml aspirate) or once Total Parenteral Nutrition (TPN) is started. Then, BGL is monitored hourly while the insulin infusion rate will be adjusted (sliding scale method) for 2 consecutive hours with constant rate. If BGL within the targeted band, BGL can be measured within 2 to 4 hours. By some means, if adjusting the insulin infusion rate or changing between dextrose/EN/TPN, revert to hourly BGL monitoring. 
2) Enteral and Parenteral Nutrition Protocol
Enteral feeding is preferable in critical care unit compare to the parenteral nutrition. Therefore, in this study the parenteral nutrition is neglected.
The enteral nutrition is depending on the aspirates readings. Aspirate reading is measurement of gastric contents or fluid that withdraws from the body. Usually, enteral feeding starts after 24-48 hours of admittance in Intensive Care Unit (ICU) which can be summarized as:
a. The feeding is started at 20-40 mls/h continuously within 4 hours aspirate feeding tube. b. After 4 hours:
i. If aspirates less than 300mls/h, return all aspirates and increase the rate by 20mls/h every 2 cycles until it meets the patient caloric needs.
If aspirates greater than 300mls/h, return all aspirate to patient and reduce by 50% of initial rate. 
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C. ICING Physiological Model
The clinical validated Intensive Control Insulin-NutritionGlucose (ICING) [14] model is used to identify SI hourly for each patient. The aim of this model is to observe patient's BG and plasma insulin responses. This physiological model has been used in several tight glycaemic control protocols in New Zealand and Hungary [12] .
ICING model relates the rate of glucose decay to the concentration of insulin availability in the interstitium to assess insulin sensitivity (SI). SI is defined as insulin response (via pancreas) to the increase of blood glucose levels where cells can absorb blood glucose when stimulated by insulin. The model equations are defined mathematically as:
where [22] and clinical data are used to identify patient-specific stepwise SI profile with 1-hour resolution. All constant parameter values can be referred to [14] . Fig. 1 shows the simulation process of virtual patients based on clinical data obtained from ICU in HTAA. Clinical data were used to identify patient-specific SI profile via ICING model by applying iterative integral-based method [22] . Based on the SI profile and baseline measurement of BG levels, nutrition and insulin inputs, STAR virtual trial can be simulated to generate hourly BG response of the virtual patients.
D. Virtual patients and trial simulation
Then SI of the virtual patients is re-simulating again using ICING model and STAR controller. The trial simulation outcomes are based on per-cohort and per-patient statistic of insulin rate, dextrose rate and percentage of hourly blood glucose. The STAR controller used patient-specific SI to project and suggest for the next patient treatment.
For the virtual trial simulation, STAR protocol is used to monitor patient's BG and nutrition inputs. The entry criteria of the STAR protocol is BG reading is higher than 10.0 mmol/L within 2 consecutive hours [12] . For this protocol, nurse could be freely selecting the next measurement of blood glucose either within interval of 1, 2, or 3 hour when blood glucose in the targeted band. 
E. Analysis
The percentage of blood glucose within targeted 4.4 -10.0 mmol/L will represent the performance of the protocol. The performance of the STAR protocol was compared with the performance of the HTAA ICU protocol. Furthermore, the result of this study is discuses based on median and interquartile of the blood glucose between current protocol and STAR protocol.
Since the blood glucose and insulin reading is typically skewed distribution data, nonparametric statistics are used for all comparative test in this study. In addition, the KolmogorovSmirnov test is used to calculate the p-value for all the continuous data. Results for all tests are considered statistically significant if the p-value less than 0.05.
III. RESULTS AND DISCUSSION
The whole cohort statistics for all four subgroups (123 diabetic and 87 non-diabetic for both HTAA protocol and STAR virtual trial) are summarized in Table III . The resampled means BG traces are interpolated to obtain only one BG value per hour. If data were not resampled, the comparison will be meaningless because STAR allows less frequent measurements when a patient is in the targeted band and requires one-hourly measurements when it is outside the band. Thus BG measurement will be biased towards the poor ones. Overall STAR virtual trial shows the highest percentage of BGL within the targeted band of 4.4 -10.0 mmol/L which 82% for non-diabetic and 70.6% for diabetic cohorts respectively. In fact, STAR virtual trial also successfully reduced hyperglycaemia incidences below 25% for both cohorts. Also, the BGL median for both cohorts are relatively low between 7.1 -7.6 mmol/L in comparatively to HTAA protocol 9.1 -8.0 mmol/L which is strongly suggested that STAR is clinically relevant to be implemented in Malaysia ICU. However, the drawback of the current STAR practice based on HTAA clinical data is it increases hypoglycaemia (low blood glucose) incidences especially in diabetic cohort. Thus to prevent this from happening, a "nutrition-insulin controller" needs to be specifically tailored according to patient's demographics, clinical judgment from physicians and patient needs. In addition, the proposed controller can also be adjusted to suit different type of nutrition inputs instead of just one nutrition type (i.e. Glucerna) that has been implemented in ICU Christchurch Hospital [12] .
The goal nutrition for each patient was set to 25 kCal/kg/day based on patient weight for both STAR and HTAA protocols which 30 -40% calories is estimated from carbohydrate (depends on the nutrition types). STAR protocol normalize BGL from hyperglycaemia to targeted band by balancing insulin and nutrition inputs simultaneously. Meanwhile, HTAA protocol has two separate ICU management protocols as explained earlier in methodology section which explained the same amount of insulin inputs -2 U/hr (median) given to diabetic and non-diabetic cohort for HTAA protocol. In fact, 39% of diabetes patient on HTAA protocol has BGL > 10.0 mmol/L shows insufficient insulin input were given to the patients. Briefly patients with diabetes cannot depend on endogenous insulin secretion as their pancreas is unable to secrete sufficient insulin to normalize BGL. Thus requires external insulin either by infusion or bolus (e.g. insulin pump).
Patient's BG resampled data shows improvement on reducing hyperglycaemia and hypoglycaemia incidences especially in STAR virtual trial for diabetic and non-diabetic cohorts. The performance of STAR protocol is enhanced by disregarding poor clinical data or outliers that affect protocol efficacy in order to suggest the best treatment given to the patients. In fact, frequent BG measurements (via STAR virtual trial) will increase protocol efficacy and allow the best options to treat hyperglycaemia especially for diabetic. Also STAR protocol allows forecast the next BGL based on hourly patientspecific insulin sensitivity which can be calculated using ICING model based on the prior BG measurements, insulin and nutrition inputs.
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The stochastic model of SI for STAR virtual trial can be observed in Fig.2 . It is clearly showed that SI is more variability (wider range) and the large drops in SI are relatively common and more prevalent than large increases. This is indicated by the relatively low 5 th percentile line. The main reason of low SI value might be due poor insulin/nutrition balance given to patients once HTAA protocol is commenced As stated earlier, HTAA protocol were divided into two separated protocols known as Infusion Insulin protocol and Enteral and Parenteral Nutrition protocol which both are indirectly related to each other as explained earlier in methodology section.
Another factor might be due to multiple comorbidities experienced by critically ill patients' i.e. acute kidney injury (AKI), cardiovascular or sepsis on top of diabetes. In general patient with diabetes is usually associated with other metabolic illnesses that explained the low SI value in the 5 th percentile where SI indicates the insulin reaction to lower BGL. In fact, SI is highly outlier-prone which explained the model-based is considerately dynamic to the changes in BGLs. Interestingly, although limited data obtained in a noisy and highly variable clinical setting (i.e. ICU), patient-specific SI can be easily identified given all the parameters kept as population constants based on previous studies [15, 23, 24] . Thus, making ICING physiological model applicable to simulate virtual clinical trial before applying it in ICU setting to ensure patient's safety. However, further investigation needed especially for diabetic cohort as their physiological responses in terms of BGL, insulin and nutrition inputs are quite irregular and different from non-diabetic cohort. Fig. 3(b) and (d) clearly show that patient with diabetes has erratic BG responses which is usually to be outside the targeted band. It is obvious STAR virtual trial simulation as illustrated in the figure by circle with dash line tend to control BGL within the targeted band for both cohort of diabetic and nondiabetic compared to HTAA protocol (i.e. the cross with solid line). Few clinical data points in Fig. 3(b) and (d) were unfitted to the physiological model simulation which means either patients received insufficient nutrition/insulin while they underwent BG management in ICU. Thus, a compliance study need to be done at once to ensure that patient is well treated according to either STAR protocol or HTAA protocol. However, BG responses in non-diabetic cohort as shown in Fig. 3 (a) and (c) are fitted well with ICING model simulation. Literally, ICING model is well-defined as it precisely representing the glucose-insulin kinetics of non-diabetes patients compare to diabetics. Hence the physiological model (i.e. ICING) used in this study is clearly relevant only to non-diabetic instead of diabetic. Although the model reflects the biological mechanism of insulin kinetics with distinctive routes for insulin clearance and transport from plasma, yet it still inaccurately to count for endogenous insulin secretion produced in pancreas especially for diabetes cohort. Prior studies [21, 25, 26] have been conducted to model the insulin secretion, however the finding is still vague and yet to be discovered.
IV. CONCLUSION
In general, the outcomes of STAR virtual trials is enhanced as 82% (non-diabetic) and 70.6% (diabetic) BG levels within targeted band of 4.4 -10.0 mmol/L compare to 76.3% and 59.6% in HTAA protocol. Thus making STAR protocol a reliable and practical to be applied in current ICU setting. However, adjustment on STAR protocol need to done before it is practiced to tailor the nutrition types according to the patient's condition. The SI stochastic model illustrates wider range for diabetic cohort means that the physiological model (ICING) needs to be revised in order to account for dysfunction of pancreatic function experienced by these patients. Also, a simultaneous "nutrition-insulin controller" is a needed if IIT is applied in clinical setting to ensure that the balance of inputs in the protocol so BG level is maintain within targeted band.
